-
Johnson and Johnson 2020Q3 results: Strong sales of $21.1 billion in immunology and oncology
Time of Update: 2021-03-06
Immunology and oncology performed well in the third quarter, Johnson and Johnson achieved double-digit growth in seven branded drugs (Erleada, Darzalex, Imbruvica, Stelara, Tremfya, Opsumit, Uptravi).
-
Vaccination 1 shot to prevent COVID-19! Johnson and Johnson single-dose new crown vaccine large
Time of Update: 2021-03-03
3 ENSEMBLE study aims to assess the effectiveness and safety of Jansen COVID-19 candidate vaccines in protecting moderate to severe COVID-19, with the common primary endpoint being 14 and 28 days after vaccination.
-
Johnson and Johnson Darzalex under-skin injections are approved by the European Union
Time of Update: 2021-03-03
by many countries around the world for first-, second-line, multi-line treatment of multiple myeloma, specifically approved adaptations vary from country to country, including: (1) November 2015, as a single-drug therapy, used in the past Adult
-
Sales soared and companies such as Johnson and Johnson used this method
Time of Update: 2021-03-01
May 14, according to the National Health and Health Commission, on the 13th of this month, 0-24 hours, three new confirmed cases, all local cases (2 cases in Liaoning, 1 case in Jilin); We can see that China
-
Bayer hired Marian de Barker of Johnson and Johnson to lead the pharmaceutical business
Time of Update: 2021-03-01
DeBaker recently served as Vice President of Operations and Divestitures at Johnson and Johnson Pharmaceuticals, responsible for leading Bayer's global external pharmaceutical growth strategy and activities in all key areas of pharmaceutical innovation and alliance management.
-
Johnson and Johnson contributed the most to second-quarter revenue of $20.8 billion in cancer drug sales
Time of Update: 2021-02-27
In the second quarter of 2018, Johnson and Johnson generated revenue of $20.8 billion, of which global cancer drug sales rose 42 percent to $2.46 billion.
-
New drugs for depression! Johnson and Johnson Spravato nasal spray approved in the European Union
Time of Update: 2021-02-27
